Does Rallies show 13F holders for GPCR?

Yes. Rallies tracks hedge fund and 13F ownership data for GPCR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is GPCR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GPCR. It does not provide personalized investment advice.

GPCR (Structure Therapeutics Inc. American Depositary Shares) Stock Analysis - Hedge Fund Holdings

Structure Therapeutics Inc. American Depositary Shares (GPCR) is a publicly traded Healthcare sector company. As of May 20, 2026, GPCR trades at $36.92 with a market cap of $2.57B and a P/E ratio of -45.88. GPCR moved +2.84% today. Year to date, GPCR is -41.26%; over the trailing twelve months it is +49.45%. Its 52-week range spans $13.22 to $94.90. Analyst consensus is strong buy with an average price target of $110.69. Rallies surfaces GPCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns GPCR stock?

Hedge funds tracked by Rallies that own GPCR include Orbimed Advisors, Farallon Capital, Pentwater Capital, Duquesne Family, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Structure Therapeutics Inc. American Depositary Shares.

GPCR Key Metrics

Key financial metrics for GPCR
Metric	Value
Price	$36.92
Market Cap	$2.57B
P/E Ratio	-45.88
EPS	$-0.80
Dividend Yield	0.00%
52-Week High	$94.90
52-Week Low	$13.22
Volume	1.20M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-141.20M
Gross Margin	0.00%

Top Hedge Funds Holding GPCR

Orbimed Advisors holds 1.48M shares of GPCR, changed +26.99% as of Mar 31, 2026.
Farallon Capital holds 454.00K shares of GPCR, changed +0.00% as of Dec 31, 2025.
Pentwater Capital holds 245.00K shares of GPCR, changed +0.00% as of Mar 31, 2026.
Duquesne Family holds 37.70K shares of GPCR, changed +0.00% as of Jun 30, 2024.
Centerbook Partners holds 21.24K shares of GPCR, changed +0.00% as of Mar 31, 2026.

Latest GPCR News

Aleniglipron Achieves Over 16% Weight Loss at 44 Weeks in Phase 2 Trial — Mar 16, 2026
Structure Therapeutics Secures Phase III Funding After Low-Discontinuation Phase II Results — Feb 19, 2026

GPCR Analyst Consensus

15 analysts cover GPCR: 0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.69.

Common questions about GPCR

Who owns GPCR stock?: Hedge funds tracked by Rallies that own GPCR include Orbimed Advisors, Farallon Capital, Pentwater Capital, Duquesne Family, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Structure Therapeutics Inc. American Depositary Shares.
Does Rallies show 13F holders for GPCR?: Yes. Rallies tracks hedge fund and 13F ownership data for GPCR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GPCR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GPCR. It does not provide personalized investment advice.